Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Heidi Erickson
Manager, Pulmonary Research
Medicine
Overview
Research
More
Collaboration
(29)
Sairam Parthasarathy
Mutual work: 5 Grants﹒6 Proposals﹒1 Supervisor
Collaboration Details
Kenneth Knox
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Jarrod Mosier
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Franz Rischard
Mutual work: 4 Proposals﹒2 Grants
Collaboration Details
Mrinalini Kala
Mutual work: 8 Grants﹒7 Proposals
Collaboration Details
Page 1 of 6
Previous page
Next page
Grants
(18)
Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
Active
·
2024
·
$0 / $404.1K
·
External
molecular diagnostics,
cancer diagnosis,
pleural effusions,
medical testing
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2024
·
$0 / $359.6K
·
External
sleep disturbances,
sars-cov-2 infection,
post-acute sequelae
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2024
·
$0 / $167.9K
·
External
post-acute sequelae,
sars-cov-2,
evaluation protocol
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2024
·
$0 / $167.9K
·
External
post-acute sequelae,
sars-cov-2 infection,
intervention evaluation
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $1.8M
·
External
viral persistence,
immune dysregulation,
interventions evaluation,
sars-cov-2,
post-acute sequelae
Page 1 of 4
Previous page
Next page
